Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Consensus PT from Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTX) have been given a consensus rating of “Moderate Buy” by the five research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $12.95.

A number of equities analysts have weighed in on the company. HC Wainwright reissued a “buy” rating and set a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com raised Aemetis to a “sell” rating in a report on Monday, January 27th.

Hedge Funds Weigh In On Aemetis

A number of large investors have recently made changes to their positions in the company. FMR LLC grew its holdings in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after buying an additional 9,137 shares in the last quarter. Clear Harbor Asset Management LLC bought a new stake in shares of Aemetis in the fourth quarter valued at about $44,000. Bank of New York Mellon Corp grew its stake in shares of Aemetis by 29.6% in the fourth quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company’s stock valued at $247,000 after acquiring an additional 20,961 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Aemetis in the fourth quarter valued at about $87,000. Finally, Barclays PLC increased its position in Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the period. Institutional investors own 27.02% of the company’s stock.

Aemetis Trading Up 0.5 %

Shares of AMTX opened at $2.16 on Friday. The company’s fifty day simple moving average is $2.85 and its 200 day simple moving average is $2.86. Aemetis has a 1-year low of $2.04 and a 1-year high of $7.03. The company has a market cap of $107.44 million, a price-to-earnings ratio of -0.96 and a beta of 1.44.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the business earned ($0.59) EPS. As a group, research analysts forecast that Aemetis will post -2.07 earnings per share for the current year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.